Company Filing History:
Years Active: 2024
Title: Yujia Dang: Innovator in Antibody Research
Introduction
Yujia Dang is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of biotechnology, particularly in the development of novel antibodies. His work focuses on innovative solutions for treatment and diagnosis, showcasing his commitment to advancing medical science.
Latest Patents
Yujia Dang holds 1 patent for his invention titled "Antibodies binding TNFR2 and uses thereof." This patent describes a novel antibody and antibody fragment that specifically binds to TNFR2. The invention also includes a composition comprising the antibody or antibody fragment, as well as a nucleic acid encoding the antibody. Furthermore, it outlines the use of the antibody and antibody fragment for treatment and diagnosis, highlighting its potential impact on healthcare.
Career Highlights
Yujia Dang is associated with Nanjing Leads Biolabs Co., Ltd., where he continues to push the boundaries of antibody research. His work is characterized by a strong focus on practical applications that can lead to improved therapeutic options for patients.
Collaborations
Yujia has collaborated with notable colleagues, including Xiaoqiang Kang and Shoupeng Lai. These partnerships enhance the research environment and foster innovation within the company.
Conclusion
Yujia Dang's contributions to antibody research exemplify the spirit of innovation in biotechnology. His patent on antibodies binding TNFR2 represents a significant advancement in the field, with promising applications for treatment and diagnosis.